Vials-blinding solution (container and its use in packaging, for example packaging for remedies)

Abstract

The invention relates to a container ( 1.1 - 1.5 ) and a packaging, for example packaging for remedies, comprising a plurality of such containers. Containers and packaging of the type according to the invention are used, for example, in clinical trials of drugs or remedies. According to the invention, it is intended to provide the container or containers with a covering ( 8 ) which is arranged on the outside of the container wall and either changes the appearance of the container wall or makes the pharmaceutical formulation ( 7.1 - 7.5 ) appear opaque through any transparent container wall, so that the appearance of the container wall and/or of the pharmaceutical formulation, for example whether it is a coloured, liquid, pulverulent, lyophilized or granular formulation, is visually undetectable for a user.

1 - 10 . (Cancelled)  
   
   
       11 . A container for containing a pharmaceutical formulation comprising: 
 one of a transparent and a nontransparent wall having an outside surface;    a covering provided on the outside surface of the container wall being formed in such a way that the appearance of the container wall or of the pharmaceutical formulation selectively received within the container is visually undetectable for a user.    
   
   
       12 . A container according to  claim 11 , wherein the container is used in a clinical trial wherein the user is a test subject taking the pharmaceutical formulation.  
   
   
       13 . A container according to  claim 11 , wherein the container is one of a blister pack, a vial, a syringe and an ampoule.  
   
   
       14 . A container according to  claim 11 , wherein when the container wall is nontransparent, the covering changes the appearance of the container wall and when the container wall is transparent, the pharmaceutical formulation appears opaque.  
   
   
       15 . A container according to  claim 11 , wherein the covering includes a premolded plastic jacket fitted against the container wall.  
   
   
       16 . A container according to  claim 15 , wherein the plastic jacket is arranged detachably on the container wall, and further that the jacket is closed by means of an adhesive strip enclosing the jacket or by means of an adhesive.  
   
   
       17 . A container according to  claim 15 , wherein the plastic jacket is permanently attached to the container wall, and further that the jacket is firmly and permanently bonded to the container wall.  
   
   
       18 . A container according to  claim 11 , wherein the covering is arranged detachably on the container wall.  
   
   
       19 . A container according to  claim 11 , wherein the covering is permanently attached to the container wall.  
   
   
       20 . A container according to  claim 11 , further including at least one of an outer note and a label, and wherein the at least one of the outer note and the label is wrapped around the covering.  
   
   
       21 . A container according to  claim 11 , wherein the covering is colored one of black and white.  
   
   
       22 . A container according to  claim 11 , wherein the covering is one of nontransparent and translucent.  
   
   
       23 . A container according to  claim 11 , wherein the covering is milky or cloudy.  
   
   
       24 . A container according to  claim 11 , wherein the container is one of an ampoule, syringe and vial.  
   
   
       25 . A packaging for remedies comprising: 
 a plurality of containers each selectively containing a pharmaceutical formulation where the containers are all provided with a covering so that the appearance of the container walls or the pharmaceutical formulations are visually indistinguishable from one another for the user.    
   
   
       26 . A packaging according to  claim 25 , wherein the containers are used in a clinical trial and wherein the user is a test subject taking the pharmaceutical formulation.  
   
   
       27 . A packaging according to  claim 25 , wherein when the container wall is nontransparent, the covering changes the appearance of the container wall and when the container wall is transparent, the pharmaceutical formulation appears opaque.  
   
   
       28 . A packaging according to  claim 25 , wherein the container is one of a blister pack, a vial, a syringe and an ampoule.  
   
   
       29 . A packaging according to  claim 25 , wherein the pharmaceutical formulation is one of a solid drug, a liquid drug and a drug to be dissolved in a liquid.